Massimo Corradi

A European Respiratory Society technical standard: exhaled biomarkers in lung disease

Ildikó Horváth, Peter J. Barnes, Stelios Loukides et al. · European Respiratory Journal · 2017 · 611 citations · Full text

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

Alberto Papi, Jørgen Vestbo, Leonardo M. Fabbri et al. · The Lancet · 2018 · 611 citations · Full text

Advanced Lung Disease, Respiratory Therapy, Pulmonary Pharmacology +5

Increased 8-Isoprostane, a Marker of Oxidative Stress, in Exhaled Condensate of Asthma Patients

Paolo Montuschi, Massimo Corradi, Giovanni Ciabattoni et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 552 citations

Exhaled 8-Isoprostane as an <i>In Vivo</i> Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers

Paolo Montuschi, John V. Collins, Giovanni Ciabattoni et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 547 citations

Asthma, Allergy, Lung Inflammation +13

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi et al. · The Lancet · 2017 · 433 citations · Full text

Pulmonary Care, Pulmonary Pharmacology, Parallel Group +4